Skip to main content

Open Access UNITE4TB: a new consortium for clinical drug and regimen development for TB

Download Article:

No Abstract

Document Type: Editorial

Affiliations: 1: Lung Diseases, Radboud University Medical Center, Nijmegen, The Netherlands 2: Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany 3: Clinical Research Unit, Hospital for Tropical Diseases, Oxford University, Oxford, UK 4: Global Health Portfolio, 5: Lygature, Utrecht, The Netherlands 6: Global Health, GSK, Brentford, UK 7: Department of Infectious Diseases and Tropical Medicine, Munich, Germany 8: www.unite4TB.org_contents">

Publication date: November 1, 2021

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content